Praxis Precision Medicines, Inc. Announces Inducement
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Source: globenewswire.com
Nasdaq Prax News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Prax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Prax Today - Breaking & Trending Today
Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $105.00 price objective on the stock. Other analysts have also issued reports about the company. Wedbush boosted their price objective on Praxis Precision […]
Source: dailypolitical.com
HC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They presently have a $105.00 target price on the stock. HC Wainwright’s target price would indicate a potential upside of 98.56% from the company’s previous […]
Source: wkrb13.com
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Up to $50.74
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $50.74, but opened at $52.12. Praxis Precision Medicines shares last traded at $51.46, with a volume of 28,341 shares trading hands. Analyst Upgrades and Downgrades Several research analysts recently […]
Source: dailypolitical.com
Praxis Precision Medicines (NASDAQ:PRAX) Receives "Buy" Rating from HC Wainwright
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $105.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 77.54% from the stock’s current price. A […]
Source: tickerreport.com